 | • レポートコード：GIR-2104Z03994 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、CRISPR/Cas9のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。CRISPR/Cas9の種類別市場規模（ゲノム編集、遺伝子工学、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株工学）、用途別市場規模（バイオテクノロジー産業、製薬産業、学術機関、研究開発機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・CRISPR/Cas9の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Caribou Biosciences、Integrated DNA Technologies (IDT)、CRISPR Therapeutics、Merck、Mirus Bio、Editas Medicine、Takara Bio、Thermo Fisher Scientific、Horizon Discovery Group、Intellia Therapeutics、Agilent Technologies、Cellecta、GenScript、GeneCopoeia、Synthego ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ゲノム編集、遺伝子工学、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株工学 ・用途別分析2016年-2026年：バイオテクノロジー産業、製薬産業、学術機関、研究開発機関 ・CRISPR/Cas9の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・CRISPR/Cas9のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・CRISPR/Cas9のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・CRISPR/Cas9の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・CRISPR/Cas9の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The CRISPR/Cas9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global CRISPR/Cas9 size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global CRISPR/Cas9 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
CRISPR/Cas9 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market segment by Application, can be divided into
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Market segment by players, this report covers
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of CRISPR/Cas9
1.2 Classification of CRISPR/Cas9 by Type
1.2.1 Overview: Global CRISPR/Cas9 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CRISPR/Cas9 Revenue Market Share by Type in 2020
1.2.3 Genome Editing
1.2.4 Genetic engineering
1.2.5 gRNA Database/Gene Librar
1.2.6 CRISPR Plasmid
1.2.7 Human Stem Cells
1.2.8 Genetically Modified Organisms/Crops
1.2.9 Cell Line Engineering
1.3 Global CRISPR/Cas9 Market by Application
1.3.1 Overview: Global CRISPR/Cas9 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Global CRISPR/Cas9 Market Size & Forecast
1.5 Global CRISPR/Cas9 Market Size and Forecast by Region
1.5.1 Global CRISPR/Cas9 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CRISPR/Cas9 Market Size by Region, (2016-2021)
1.5.3 North America CRISPR/Cas9 Market Size and Prospect (2016-2026)
1.5.4 Europe CRISPR/Cas9 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CRISPR/Cas9 Market Size and Prospect (2016-2026)
1.5.6 South America CRISPR/Cas9 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CRISPR/Cas9 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CRISPR/Cas9 Market Drivers
1.6.2 CRISPR/Cas9 Market Restraints
1.6.3 CRISPR/Cas9 Trends Analysis
2 Company Profiles
2.1 Caribou Biosciences
2.1.1 Caribou Biosciences Details
2.1.2 Caribou Biosciences Major Business
2.1.3 Caribou Biosciences CRISPR/Cas9 Product and Solutions
2.1.4 Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Caribou Biosciences Recent Developments and Future Plans
2.2 Integrated DNA Technologies (IDT)
2.2.1 Integrated DNA Technologies (IDT) Details
2.2.2 Integrated DNA Technologies (IDT) Major Business
2.2.3 Integrated DNA Technologies (IDT) CRISPR/Cas9 Product and Solutions
2.2.4 Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Integrated DNA Technologies (IDT) Recent Developments and Future Plans
2.3 CRISPR Therapeutics
2.3.1 CRISPR Therapeutics Details
2.3.2 CRISPR Therapeutics Major Business
2.3.3 CRISPR Therapeutics CRISPR/Cas9 Product and Solutions
2.3.4 CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 CRISPR Therapeutics Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck CRISPR/Cas9 Product and Solutions
2.4.4 Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 Mirus Bio
2.5.1 Mirus Bio Details
2.5.2 Mirus Bio Major Business
2.5.3 Mirus Bio CRISPR/Cas9 Product and Solutions
2.5.4 Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Mirus Bio Recent Developments and Future Plans
2.6 Editas Medicine
2.6.1 Editas Medicine Details
2.6.2 Editas Medicine Major Business
2.6.3 Editas Medicine CRISPR/Cas9 Product and Solutions
2.6.4 Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Editas Medicine Recent Developments and Future Plans
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio CRISPR/Cas9 Product and Solutions
2.7.4 Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Takara Bio Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific CRISPR/Cas9 Product and Solutions
2.8.4 Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group CRISPR/Cas9 Product and Solutions
2.9.4 Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 Intellia Therapeutics
2.10.1 Intellia Therapeutics Details
2.10.2 Intellia Therapeutics Major Business
2.10.3 Intellia Therapeutics CRISPR/Cas9 Product and Solutions
2.10.4 Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Intellia Therapeutics Recent Developments and Future Plans
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business
2.11.3 Agilent Technologies CRISPR/Cas9 Product and Solutions
2.11.4 Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Agilent Technologies Recent Developments and Future Plans
2.12 Cellecta
2.12.1 Cellecta Details
2.12.2 Cellecta Major Business
2.12.3 Cellecta CRISPR/Cas9 Product and Solutions
2.12.4 Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Cellecta Recent Developments and Future Plans
2.13 GenScript
2.13.1 GenScript Details
2.13.2 GenScript Major Business
2.13.3 GenScript CRISPR/Cas9 Product and Solutions
2.13.4 GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 GenScript Recent Developments and Future Plans
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business
2.14.3 GeneCopoeia CRISPR/Cas9 Product and Solutions
2.14.4 GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 GeneCopoeia Recent Developments and Future Plans
2.15 Synthego
2.15.1 Synthego Details
2.15.2 Synthego Major Business
2.15.3 Synthego CRISPR/Cas9 Product and Solutions
2.15.4 Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Synthego Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CRISPR/Cas9 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 CRISPR/Cas9 Players Market Share
3.2.2 Top 10 CRISPR/Cas9 Players Market Share
3.2.3 Market Competition Trend
3.3 CRISPR/Cas9 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CRISPR/Cas9 Revenue and Market Share by Type (2016-2021)
4.2 Global CRISPR/Cas9 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global CRISPR/Cas9 Revenue Market Share by Application (2016-2021)
5.2 CRISPR/Cas9 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America CRISPR/Cas9 Revenue by Type (2016-2026)
6.2 North America CRISPR/Cas9 Revenue by Application (2016-2026)
6.3 North America CRISPR/Cas9 Market Size by Country
6.3.1 North America CRISPR/Cas9 Revenue by Country (2016-2026)
6.3.2 United States CRISPR/Cas9 Market Size and Forecast (2016-2026)
6.3.3 Canada CRISPR/Cas9 Market Size and Forecast (2016-2026)
6.3.4 Mexico CRISPR/Cas9 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe CRISPR/Cas9 Revenue by Type (2016-2026)
7.2 Europe CRISPR/Cas9 Revenue by Application (2016-2026)
7.3 Europe CRISPR/Cas9 Market Size by Country
7.3.1 Europe CRISPR/Cas9 Revenue by Country (2016-2026)
7.3.2 Germany CRISPR/Cas9 Market Size and Forecast (2016-2026)
7.3.3 France CRISPR/Cas9 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CRISPR/Cas9 Market Size and Forecast (2016-2026)
7.3.5 Russia CRISPR/Cas9 Market Size and Forecast (2016-2026)
7.3.6 Italy CRISPR/Cas9 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CRISPR/Cas9 Revenue by Type (2016-2026)
8.2 Asia-Pacific CRISPR/Cas9 Revenue by Application (2016-2026)
8.3 Asia-Pacific CRISPR/Cas9 Market Size by Region
8.3.1 Asia-Pacific CRISPR/Cas9 Revenue by Region (2016-2026)
8.3.2 China CRISPR/Cas9 Market Size and Forecast (2016-2026)
8.3.3 Japan CRISPR/Cas9 Market Size and Forecast (2016-2026)
8.3.4 South Korea CRISPR/Cas9 Market Size and Forecast (2016-2026)
8.3.5 India CRISPR/Cas9 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CRISPR/Cas9 Market Size and Forecast (2016-2026)
8.3.7 Australia CRISPR/Cas9 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America CRISPR/Cas9 Revenue by Type (2016-2026)
9.2 South America CRISPR/Cas9 Revenue by Application (2016-2026)
9.3 South America CRISPR/Cas9 Market Size by Country
9.3.1 South America CRISPR/Cas9 Revenue by Country (2016-2026)
9.3.2 Brazil CRISPR/Cas9 Market Size and Forecast (2016-2026)
9.3.3 Argentina CRISPR/Cas9 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CRISPR/Cas9 Revenue by Type (2016-2026)
10.2 Middle East & Africa CRISPR/Cas9 Revenue by Application (2016-2026)
10.3 Middle East & Africa CRISPR/Cas9 Market Size by Country
10.3.1 Middle East & Africa CRISPR/Cas9 Revenue by Country (2016-2026)
10.3.2 Turkey CRISPR/Cas9 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CRISPR/Cas9 Market Size and Forecast (2016-2026)
10.3.4 UAE CRISPR/Cas9 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global CRISPR/Cas9 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CRISPR/Cas9 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CRISPR/Cas9 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CRISPR/Cas9 Revenue (USD Million) by Region (2016-2021)
Table 5. Global CRISPR/Cas9 Revenue Market Share by Region (2021-2026)
Table 6. Caribou Biosciences Corporate Information, Head Office, and Major Competitors
Table 7. Caribou Biosciences Major Business
Table 8. Caribou Biosciences CRISPR/Cas9 Product and Solutions
Table 9. Caribou Biosciences CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Integrated DNA Technologies (IDT) Corporate Information, Head Office, and Major Competitors
Table 11. Integrated DNA Technologies (IDT) Major Business
Table 12. Integrated DNA Technologies (IDT) CRISPR/Cas9 Product and Solutions
Table 13. Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. CRISPR Therapeutics Major Business
Table 16. CRISPR Therapeutics CRISPR/Cas9 Product and Solutions
Table 17. CRISPR Therapeutics CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck CRISPR/Cas9 Product and Solutions
Table 21. Merck CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Mirus Bio Corporate Information, Head Office, and Major Competitors
Table 23. Mirus Bio Major Business
Table 24. Mirus Bio CRISPR/Cas9 Product and Solutions
Table 25. Mirus Bio CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 27. Editas Medicine Major Business
Table 28. Editas Medicine CRISPR/Cas9 Product and Solutions
Table 29. Editas Medicine CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Takara Bio Corporate Information, Head Office, and Major Competitors
Table 31. Takara Bio Major Business
Table 32. Takara Bio CRISPR/Cas9 Product and Solutions
Table 33. Takara Bio CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Scientific Major Business
Table 36. Thermo Fisher Scientific CRISPR/Cas9 Product and Solutions
Table 37. Thermo Fisher Scientific CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Horizon Discovery Group Corporate Information, Head Office, and Major Competitors
Table 39. Horizon Discovery Group Major Business
Table 40. Horizon Discovery Group CRISPR/Cas9 Product and Solutions
Table 41. Horizon Discovery Group CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Intellia Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Intellia Therapeutics Major Business
Table 44. Intellia Therapeutics CRISPR/Cas9 Product and Solutions
Table 45. Intellia Therapeutics CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 47. Agilent Technologies Major Business
Table 48. Agilent Technologies CRISPR/Cas9 Product and Solutions
Table 49. Agilent Technologies CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Cellecta Corporate Information, Head Office, and Major Competitors
Table 51. Cellecta Major Business
Table 52. Cellecta CRISPR/Cas9 Product and Solutions
Table 53. Cellecta CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. GenScript Corporate Information, Head Office, and Major Competitors
Table 55. GenScript Major Business
Table 56. GenScript CRISPR/Cas9 Product and Solutions
Table 57. GenScript CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. GeneCopoeia Corporate Information, Head Office, and Major Competitors
Table 59. GeneCopoeia Major Business
Table 60. GeneCopoeia CRISPR/Cas9 Product and Solutions
Table 61. GeneCopoeia CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Synthego Corporate Information, Head Office, and Major Competitors
Table 63. Synthego Major Business
Table 64. Synthego CRISPR/Cas9 Product and Solutions
Table 65. Synthego CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global CRISPR/Cas9 Revenue (USD Million) by Players (2019-2021)
Table 67. Global CRISPR/Cas9 Revenue Share by Players (2019-2021)
Table 68. Breakdown of CRISPR/Cas9 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. CRISPR/Cas9 Players Head Office, Products and Services Provided
Table 70. CRISPR/Cas9 Mergers & Acquisitions in the Past Five Years
Table 71. CRISPR/Cas9 New Entrants and Expansion Plans
Table 72. Global CRISPR/Cas9 Revenue (USD Million) by Type (2016-2021)
Table 73. Global CRISPR/Cas9 Revenue Share by Type (2016-2021)
Table 74. Global CRISPR/Cas9 Revenue Forecast by Type (2021-2026)
Table 75. Global CRISPR/Cas9 Revenue by Application (2016-2021)
Table 76. Global CRISPR/Cas9 Revenue Forecast by Application (2021-2026)
Table 77. North America CRISPR/Cas9 Revenue by Type (2016-2021) & (USD Million)
Table 78. North America CRISPR/Cas9 Revenue by Type (2021-2026) & (USD Million)
Table 79. North America CRISPR/Cas9 Revenue by Application (2016-2021) & (USD Million)
Table 80. North America CRISPR/Cas9 Revenue by Application (2021-2026) & (USD Million)
Table 81. North America CRISPR/Cas9 Revenue by Country (2016-2021) & (USD Million)
Table 82. North America CRISPR/Cas9 Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe CRISPR/Cas9 Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe CRISPR/Cas9 Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe CRISPR/Cas9 Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe CRISPR/Cas9 Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe CRISPR/Cas9 Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe CRISPR/Cas9 Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific CRISPR/Cas9 Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific CRISPR/Cas9 Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific CRISPR/Cas9 Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific CRISPR/Cas9 Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific CRISPR/Cas9 Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific CRISPR/Cas9 Revenue by Region (2021-2026) & (USD Million)
Table 95. South America CRISPR/Cas9 Revenue by Type (2016-2021) & (USD Million)
Table 96. South America CRISPR/Cas9 Revenue by Type (2021-2026) & (USD Million)
Table 97. South America CRISPR/Cas9 Revenue by Application (2016-2021) & (USD Million)
Table 98. South America CRISPR/Cas9 Revenue by Application (2021-2026) & (USD Million)
Table 99. South America CRISPR/Cas9 Revenue by Country (2016-2021) & (USD Million)
Table 100. South America CRISPR/Cas9 Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa CRISPR/Cas9 Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa CRISPR/Cas9 Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa CRISPR/Cas9 Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa CRISPR/Cas9 Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa CRISPR/Cas9 Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa CRISPR/Cas9 Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CRISPR/Cas9 Picture
Figure 2. Global CRISPR/Cas9 Revenue Market Share by Type in 2020
Figure 3. Genome Editing
Figure 4. Genetic engineering
Figure 5. gRNA Database/Gene Librar
Figure 6. CRISPR Plasmid
Figure 7. Human Stem Cells
Figure 8. Genetically Modified Organisms/Crops
Figure 9. Cell Line Engineering
Figure 10. CRISPR/Cas9 Revenue Market Share by Application in 2020
Figure 11. Biotechnology Companies Picture
Figure 12. Pharmaceutical Companies Picture
Figure 13. Academic Institutes Picture
Figure 14. Research and Development Institutes Picture
Figure 15. Global CRISPR/Cas9 Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global CRISPR/Cas9 Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global CRISPR/Cas9 Revenue Market Share by Region (2016-2026)
Figure 18. Global CRISPR/Cas9 Revenue Market Share by Region in 2020
Figure 19. North America CRISPR/Cas9 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe CRISPR/Cas9 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific CRISPR/Cas9 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America CRISPR/Cas9 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. CRISPR/Cas9 Market Drivers
Figure 24. CRISPR/Cas9 Market Restraints
Figure 25. CRISPR/Cas9 Market Trends
Figure 26. Caribou Biosciences Recent Developments and Future Plans
Figure 27. Integrated DNA Technologies (IDT) Recent Developments and Future Plans
Figure 28. CRISPR Therapeutics Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. Mirus Bio Recent Developments and Future Plans
Figure 31. Editas Medicine Recent Developments and Future Plans
Figure 32. Takara Bio Recent Developments and Future Plans
Figure 33. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 34. Horizon Discovery Group Recent Developments and Future Plans
Figure 35. Intellia Therapeutics Recent Developments and Future Plans
Figure 36. Agilent Technologies Recent Developments and Future Plans
Figure 37. Cellecta Recent Developments and Future Plans
Figure 38. GenScript Recent Developments and Future Plans
Figure 39. GeneCopoeia Recent Developments and Future Plans
Figure 40. Synthego Recent Developments and Future Plans
Figure 42. Global CRISPR/Cas9 Revenue Share by Players in 2020
Figure 43. CRISPR/Cas9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players CRISPR/Cas9 Revenue Market Share in 2020
Figure 45. Global Top 10 Players CRISPR/Cas9 Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global CRISPR/Cas9 Revenue Share by Type in 2020
Figure 48. Global CRISPR/Cas9 Market Share Forecast by Type (2021-2026)
Figure 49. Global CRISPR/Cas9 Revenue Share by Application in 2020
Figure 50. Global CRISPR/Cas9 Market Share Forecast by Application (2021-2026)
Figure 51. North America CRISPR/Cas9 Sales Market Share by Type (2016-2026)
Figure 52. North America CRISPR/Cas9 Sales Market Share by Application (2016-2026)
Figure 53. North America CRISPR/Cas9 Revenue Market Share by Country (2016-2026)
Figure 54. United States CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe CRISPR/Cas9 Sales Market Share by Type (2016-2026)
Figure 58. Europe CRISPR/Cas9 Sales Market Share by Application (2016-2026)
Figure 59. Europe CRISPR/Cas9 Revenue Market Share by Country (2016-2026)
Figure 60. Germany CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific CRISPR/Cas9 Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific CRISPR/Cas9 Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific CRISPR/Cas9 Revenue Market Share by Region (2016-2026)
Figure 68. China CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America CRISPR/Cas9 Sales Market Share by Type (2016-2026)
Figure 75. South America CRISPR/Cas9 Sales Market Share by Application (2016-2026)
Figure 76. South America CRISPR/Cas9 Revenue Market Share by Country (2016-2026)
Figure 77. Brazil CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa CRISPR/Cas9 Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa CRISPR/Cas9 Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa CRISPR/Cas9 Revenue Market Share by Country (2016-2026)
Figure 82. Turkey CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE CRISPR/Cas9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
世界のCRISPR・CRISPR関連遺伝子市場規模・現状・予測（2021年-2027年） CRISPR is a type of gene-editing technology that lets scientists more rapidly and accurately 'cut' and 'paste' genes into DNA. Market Analysis and Insights: Global CRISPR And CRISPR-Associated Genes Market The global CRISPR And CRISPR-Associated Genes market size is projected to reach US$ XX million…- 世界のCRISPR・CRISPR関連遺伝子市場規模・現状・予測（2021年-2027年） CRISPR is a type of gene-editing technology that lets scientists more rapidly and accurately 'cut' and 'paste' genes into DNA. Market Analysis and Insights: Global CRISPR And CRISPR-Associated Genes Market The global CRISPR And CRISPR-Associated Genes market size is projected to reach US$ XX million…
- 世界のCRISPR・Cas遺伝子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global CRISPR and Cas Genes Market The global CRISPR and Cas Genes market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の遺伝子編集市場規模・現状・予測（2021年-2027年） Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication th…
- 世界のゲノム編集市場規模・現状・予測（2021年-2027年） Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific doub…